NCT01584141View on ClinicalTrials.gov

Study of Lymphoma in Asia

CompletedOBSERVATIONAL
Enrollment

13,433

Participants

Timeline

Start Date

July 5, 2011

Primary Completion Date

July 10, 2018

Study Completion Date

July 10, 2018

Conditions
Lymphoma, FollicularLymphoma, Non-HodgkinMultiple MyleomaLympocytic, FollicularLeukemiaHodgkin Lymphoma
Trial Locations (4)

300060

Tianjin Medical University Cancer Institute & Hospital, Hexi District

610041

West China Hospital of Sichuan University, Sichuan

Unknown

Queen Mary Hospital, Sai Ying Pun

Buddhis Dalin Tzu Chi General Hospital, Dalin Town

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01584141 - Study of Lymphoma in Asia | Biotech Hunter | Biotech Hunter